Pain News and Research

Latest Pain News and Research

Global travel, climate warming could create right conditions for chikungunya outbreaks in the U.S.

Global travel and climate warming could be creating the right conditions for outbreaks of a new virus in this country, according to a new Cornell University computer model.

18 Dec 2012

GSK receives FDA approval for FLUARIX QUADRIVALENT to treat seasonal flu

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX QUADRIVALENT (Influenza Virus Vaccine) for the immunisation of children (three years and older) and adults to help prevent disease caused by seasonal influenza (flu) virus subtypes A and type B contained in the vaccine.

17 Dec 2012

University of North Carolina awards 13th Perl prize to two NTNU-Trondheim scientists

The University of North Carolina at Chapel Hill has awarded the 13th Perl-UNC Neuroscience prize jointly to Edvard and May-Britt Moser at the Norwegian University of Science and Technology (NTNU-Trondheim) in Trondheim, Norway.

17 Dec 2012

Abiraterone improves outcomes for prostate cancer prior to chemo

Treatment with abiraterone acetate, an androgen biosynthesis inhibitor, may benefit patients with progressive metastatic castration-resistant prostate cancer who have not yet undergone chemotherapy, report researchers.

17 Dec 2012

Human nociception genes mapped out

Researchers have uncovered a “network map” of genes that are involved in pain perception, which they say may help identify new analgesic drugs.

17 Dec 2012

Alexian Brothers Health System implements online service to reduce wait times in ERs

Hospitals across the country are investigating ways to improve their patients' experience through decreasing waiting times in emergency rooms and in immediate care settings.

17 Dec 2012

ProMining Therapeutics, Roche to develop small molecule therapeutics for type 2 diabetes mellitus

ProMining Therapeutics, Ltd. today announced a new collaboration with Roche in the field of type 2 diabetes mellitus.

17 Dec 2012

New research reveals music's health benefits

Music has been incorporated into medical practice since before the ancient Greeks. However, though practitioners have been convinced of music's health benefits for thousands of years, there had been little peer-reviewed research to back them up. But recent studies are providing an empirical backbone for the anecdotal evidence.

17 Dec 2012

Pelvic exams frequently performed for reasons that are medically unjustified

The pelvic exam, a standard part of a woman's gynecologic checkup, frequently is performed for reasons that are medically unjustified, according to the authors of a UCSF study that may lay the groundwork for future changes to medical practice.

17 Dec 2012

Genesee Health Plan joins Disparities and Cardiac Health Program initiative

MPRO, Michigan's Quality Improvement Organization, announced that Genesee Health Plan is joining its Disparities and Cardiac Health Program, a special project headed by the Centers for Medicare & Medicaid Services.

15 Dec 2012

Banner MD Anderson Cancer Center to expand its outpatient cancer facility

Banner MD Anderson Cancer Center on the Banner Gateway campus will break ground in January 2013 on an expansion of its outpatient cancer facility, offering a new service and additional equipment and treatment areas to meet the needs of its rapidly growing patient population.

15 Dec 2012

AcelRx announces top-line data from Sufentanil NanoTab PCA System Phase 3 trial

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that top-line data from its previously announced open-label, active-comparator study of its lead product candidate, the Sufentanil NanoTab PCA System, will be featured in poster presentations to be held at the 66th annual New York State Society of Anesthesiologists PostGraduate Assembly meeting in New York City to be held December 14-18, 2012.

15 Dec 2012

Novartis receives FDA approval for Signifor injection to treat Cushing's disease

The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection for the treatment of Cushing's disease patients who cannot be helped through surgery.

15 Dec 2012

Sister Kenny Rehabilitation Institute and Courage Center announce merger agreement

In a bold move meant to advance the care and services provided to the disability community, Courage Center and Allina Health announced today that their boards of directors have approved a proposed merger between the Sister Kenny Rehabilitation Institute and Courage Center.

15 Dec 2012

Iclusig gets FDA approval for two rare blood and bone marrow diseases

The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.

15 Dec 2012

Research roundup: Workers' insurance costs vary depending on employers' size; Seniors mental health needs often unmet

Survey -- The authors of this analysis provide a detailed look at the availability of health coverage at small and large employers, as well as the variations in plan costs and cost-sharing requirements.

15 Dec 2012

Significant correlation between vitamin D and excessive daytime sleepiness

A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor.

14 Dec 2012

FDA approves GSK’s raxibacumab to treat inhalational anthrax

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.

14 Dec 2012

GSK receives FDA approval for raxibacumab to treat inhalational anthrax

The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis. Raxibacumab also is approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.

14 Dec 2012

FDA grants accelerated approval to ARIAD’s Iclusig for treatment of CML, Ph+ ALL

ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.

14 Dec 2012

Pain News and Research

Latest Pain News and Research

Global travel, climate warming could create right conditions for chikungunya outbreaks in the U.S.

GSK receives FDA approval for FLUARIX QUADRIVALENT to treat seasonal flu

University of North Carolina awards 13th Perl prize to two NTNU-Trondheim scientists

Abiraterone improves outcomes for prostate cancer prior to chemo

Human nociception genes mapped out

Alexian Brothers Health System implements online service to reduce wait times in ERs

ProMining Therapeutics, Roche to develop small molecule therapeutics for type 2 diabetes mellitus

New research reveals music's health benefits

Pelvic exams frequently performed for reasons that are medically unjustified

Genesee Health Plan joins Disparities and Cardiac Health Program initiative

Banner MD Anderson Cancer Center to expand its outpatient cancer facility

AcelRx announces top-line data from Sufentanil NanoTab PCA System Phase 3 trial

Novartis receives FDA approval for Signifor injection to treat Cushing's disease

Sister Kenny Rehabilitation Institute and Courage Center announce merger agreement

Iclusig gets FDA approval for two rare blood and bone marrow diseases

Research roundup: Workers' insurance costs vary depending on employers' size; Seniors mental health needs often unmet

Significant correlation between vitamin D and excessive daytime sleepiness

FDA approves GSK’s raxibacumab to treat inhalational anthrax

GSK receives FDA approval for raxibacumab to treat inhalational anthrax

FDA grants accelerated approval to ARIAD’s Iclusig for treatment of CML, Ph+ ALL

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in